13 results on '"Falabella, G."'
Search Results
2. Isolation, characterization and microincapsulation of neonatal porcine Sertoli cells obtained from a specific pathogen free (SPF) herd
- Author
-
Luca, G., Mancuso, F., Calvitti, M., Arato, I., Falabella, G., Bufalari, A., Lombardi, G., Di Meo, A., De Monte, V., Fallarino, F., Lilli, C., Bellucci, C., Giovagnoli, S., Tresoldi, E., Baroni, T., Aglietti, M.C., Bodo, M., and Calafiore, R.
- Subjects
endocrine system ,Cell therapy ,chronic diseases ,microencapsulation ,endocrine system diseases ,digestive system - Abstract
Porcine Sertoli cells (pSC) have been successfully employed as cell therapy in pre-clinical studies of several immune-based and chronic degenerative diseases. In order to prevent any transmission of infectious adventitious agents to the cells graft recipients, we have set up, according to our previously described method (Luca et al., 2007) pSC monolayers obtained from specific pathogen free (SPF) certified neonatal pigs, born in the unique SPF colony in Italy. pSC were assessed and characterized as far as viability, by ethidium bromide and fluorescein diacetate (EB/FD), Müllerian inhibiting substance (AMH), and insulin-like 3 (INSL3), alpha-smooth muscle actin (ASMI) both by immunofluorescence (IF) and cytofluorimetric analysis (CA) were concerned. pSC were encapsulated in alginate microcapsules (MCpSC), with MCp- SC functional competence and biocompatibility being determined both in vitro, by AMH, inhibin B, TGF-beta, IGF-I secretion and in vivo in experimental animal models, respectively. Results demonstrated the high purity of our pSC monolayers (95% of AMH+cells), with negligible contamination by Leydig (2%) and peritubular cells (3%). Microencapsulation did not alter pSC viability and even after 4 months postimplantation, all the retrieved microcapsules retained morphology and function. In conclusion, we have uniquely obtained, from a SPF herd, highly purified, viable and functional pSC that might poten-tially apply to humans., Italian Journal of Anatomy and Embryology, Vol 119, No 1 (Supplement) 2014
- Published
- 2015
- Full Text
- View/download PDF
3. Alginates in Pharmaceutics and Biomedicine: Is the Future so Bright?
- Author
-
Giulia Falabella, Riccardo Calafiore, Maria Bodo, Stefano Giovagnoli, Mario Calvitti, Giovanni Luca, Maurizio Ricci, Giuseppe Basta, Aurelie Marie Madeleine Schoubben, Francesca Mancuso, Paolo Blasi, Iva Arato, Giovagnoli S., Luca G., Blasi P., Mancuso F., Schoubben A., Arato I., Calvitti M., Falabella G., Basta G., Bodo M., Calafiore R., and Ricci M.
- Subjects
Engineering ,Biopolymer ,Alginates ,Alginate, microencapsulation, alginate drug delivery systems, cell microencapsulation, clinical studies, cell transplantation ,Nanotechnology ,Clinical studie ,alginate drug delivery systems ,Alginate drug delivery system ,Biopolymers ,Drug Delivery Systems ,Cell transplantation ,Biological property ,Drug Discovery ,Animals ,Humans ,clinical studies ,Microencapsulation ,Drug Carrier ,Biomedicine ,Pharmacology ,Drug Carriers ,Cell microencapsulation ,Animal ,business.industry ,Alginate ,Biotechnology ,Diabetes Mellitus, Type 1 ,Drug Design ,Drug delivery ,Pharmaceutics ,business ,Human - Abstract
Alginate represents one of the most appealing biopolymers for pharmaceutical and biomedical applications. Alginate as a biomaterial for clinical use has been established, although not free from issues. Here we provide a critical review on some of the main recent advances in alginate research in drug delivery and its prominent role in cell microencapsulation for the treatment of diseases, such as type 1 diabetes mellitus. A brief description of the basic properties of the polymer will be provided as well. Based on our experience and contributions, as well as wide research in the field, the correlation between physicochemical and biological properties of alginate systems and clinical outcomes will be investigated and discussed to address the actual future clinical impact of alginate-based delivery strategies.
- Published
- 2015
- Full Text
- View/download PDF
4. Psychopharmaphobia: Elevated fear of antidepressant medication among patients with major depression and breast cancer.
- Author
-
Markowitz JC, Hellerstein DJ, Falabella G, Lan M, Levenson J, Crew KD, and Hershman DL
- Subjects
- Humans, Female, Depression drug therapy, Depression epidemiology, Antidepressive Agents therapeutic use, Psychotherapy, Depressive Disorder, Major drug therapy, Depressive Disorder, Major epidemiology, Breast Neoplasms drug therapy
- Abstract
Competing Interests: Declaration of Competing Interest The other authors report no relevant funding or conflicts. The authors thank Barbara Milrod, M.D. and Peter Shapiro, M.D. for their comments on drafts of this manuscript.
- Published
- 2023
- Full Text
- View/download PDF
5. Maternal serum persistent organic pollutant exposure and offspring diagnosed ADHD in a national birth cohort.
- Author
-
Cheslack-Postava K, Rantakokko P, Kiviranta H, Hinkka-Yli-Salomäki S, Surcel HM, Vivio N, Falabella G, McKeague IW, Sourander A, and Brown AS
- Subjects
- Adult, Birth Cohort, Case-Control Studies, Dichlorodiphenyl Dichloroethylene, Female, Humans, Maternal Exposure adverse effects, Persistent Organic Pollutants, Pregnancy, Young Adult, Attention Deficit Disorder with Hyperactivity chemically induced, Attention Deficit Disorder with Hyperactivity epidemiology, Environmental Pollutants toxicity, Polychlorinated Biphenyls toxicity, Prenatal Exposure Delayed Effects chemically induced, Prenatal Exposure Delayed Effects epidemiology
- Abstract
Background: Evidence implicates environmental factors in attention-deficit/hyperactivity disorder (ADHD) risk. Prenatal exposures to polychlorinated biphenyls (PCBs) and the pesticide metabolite p,p'-dichlorodiphenyl dichloroethylene (DDE) have been linked to lower cognitive ability, increased impulsivity, and attention related deficits in the offspring. However, information on the relationship of these exposures to the risk of clinically diagnosed ADHD is limited., Objectives: To determine whether prenatal maternal levels of PCBs or DDE are associated with ADHD diagnosis in the offspring., Methods: The investigation was conducted in the Finnish Prenatal Study of ADHD (FIPS-ADHD), a case-control study nested in a national birth cohort. Cases were born in 1998 or 1999 and diagnosed with ADHD (ICD-9 314x or ICD-10 F90. x) according to the national Care Register for Health Care. Each case was individually matched to a control on sex, date, and place of birth. PCB congeners (PCB 74, 99, 118, 138, 153, 156, 170, 180, 183, 187) and DDE were quantified from archived prenatal maternal sera from 359 matched case-control pairs using gas chromatography - high triple quadrupole mass spectrometry. Maternal total PCBs were quantified as the sum of concentrations of the measured congeners. Associations with ADHD were examined using conditional logistic regression., Results: Maternal PCB or DDE levels greater than the 75th percentiles of the control distributions showed no evidence of association with offspring ADHD (PCBs: adjusted odds ratio (aOR) = 1.01, 95% CI = 0.63, 1.60), p = 0.98; DDE: aOR = 1.13, 95% CI = 0.71, 1.81; p = 0.60). Maternal levels of either pollutant dichotomized at the 90th percentile or considered as a continuous variable also did not show evidence for association with offspring ADHD diagnosis., Discussion: This study did not find evidence for association of maternal prenatal levels of PCBs or DDE with clinical diagnosis of offspring ADHD; however, this does not rule out the possibility of an impact on subclinical phenotypes., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
6. Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool.
- Author
-
Mandarano M, Bellezza G, Belladonna ML, Vannucci J, Gili A, Ferri I, Lupi C, Ludovini V, Falabella G, Metro G, Mondanelli G, Chiari R, Cagini L, Stracci F, Roila F, Puma F, Volpi C, and Sidoni A
- Subjects
- Adenocarcinoma pathology, Adenocarcinoma surgery, Adult, Aged, Aged, 80 and over, B7-H1 Antigen metabolism, Biomarkers, Tumor metabolism, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Non-Small-Cell Lung surgery, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Disease Progression, Female, Follow-Up Studies, Humans, Lung Neoplasms pathology, Lung Neoplasms surgery, Lymphocytes, Tumor-Infiltrating immunology, Male, Middle Aged, Prognosis, Adenocarcinoma metabolism, Carcinoma, Non-Small-Cell Lung metabolism, Carcinoma, Squamous Cell metabolism, Immunohistochemistry methods, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Lung Neoplasms metabolism
- Abstract
Indoleamine 2,3-dioxygenase 2 (IDO2) is an analog of the tryptophan degrading and immunomodulating enzyme indoleamine 2,3-dioxygenase 1 (IDO1). Although the role of IDO1 is largely understood, the function of IDO2 is not yet well-elucidated. IDO2 overexpression was documented in some human tumors, but the linkage between IDO2 expression and cancer progression is still unclear, in particular in non-small cell lung cancer (NSCLC). Immunohistochemical expression and cellular localization of IDO2 was evaluated on 191 formalin-fixed and paraffin-embedded resected NSCLC. Correlations between IDO2 expression, clinical-pathological data, tumor-infiltrating lymphocytes (TILs), immunosuppressive tumor molecules (IDO1 and programmed cell death ligand-1 - PD-L1 -) and patients' prognosis were evaluated. IDO2 high expression is strictly related to high PD-L1 level among squamous cell carcinomas group ( p = 0.012), to either intratumoral or mixed localization of TILs ( p < 0.001) and to adenocarcinoma histotype ( p < 0.001). Furthermore, a significant correlation between IDO2 high expression and poor non-small cell lung cancer prognosis was detected ( p = 0.011). The current study reaches interesting knowledge about IDO2 in non-small cell lung cancer. The close relationship between IDO2 expression, PD-L1 increased levels, TILs localization and NSCLC poor prognosis, assumed IDO2 as a potential prognostic biomarker to be exploited for optimizing innovative combined therapies with immune checkpoint inhibitors., (Copyright © 2020 Mandarano, Bellezza, Belladonna, Vannucci, Gili, Ferri, Lupi, Ludovini, Falabella, Metro, Mondanelli, Chiari, Cagini, Stracci, Roila, Puma, Volpi and Sidoni.)
- Published
- 2020
- Full Text
- View/download PDF
7. Testosterone and FSH modulate Sertoli cell extracellular secretion: Proteomic analysis.
- Author
-
Mancuso F, Calvitti M, Milardi D, Grande G, Falabella G, Arato I, Giovagnoli S, Vincenzoni F, Mancini F, Nastruzzi C, Bodo M, Baroni T, Castagnola M, Marana R, Pontecorvi A, Calafiore R, and Luca G
- Subjects
- Animals, Cell Separation, Extracellular Vesicles drug effects, Extracellular Vesicles metabolism, Extracellular Vesicles ultrastructure, Male, RNA, Messenger genetics, RNA, Messenger metabolism, Sertoli Cells drug effects, Swine, Follicle Stimulating Hormone pharmacology, Proteomics methods, Sertoli Cells metabolism, Testosterone pharmacology
- Abstract
Spermatogenesis is a highly complicated biological process that occurs in the epithelium of the seminiferous tubules. It is regulated by a complex network of endocrine and paracrine factors and by juxtacrine testicular cross-talk. Sertoli cells (SC) play a key role in spermatogenesis due to their production of trophic, differentiation and immune-modulating factors, but many of the molecular pathways of SC action remain controversial and unclear. Over the last two decades, research has focused on extracellular vesicles as an important mechanism of intercellular communication. The aim of this study was to investigate the presence of extracellular vesicles (EVs) in SC and the modulation of their content in SC after FSH and testosterone stimulation. Highly purified porcine pre-pubertal Sertoli cells were isolated according to previously established methods. After 48 h of culture with FSH or FSH + testosterone stimulation, we identified sertolian EVs containing specific mRNAs. Proteomic analysis of EVs content identified 29 proteins under non-stimulatory conditions, most of which were related to receptor binding activity. FSH stimulation induced increases in inhibin-alpha, inhibin-beta, plakoglobin, haptoglobin, D-3-phosphoglycerate dehydrogenase and sodium/potassium-transporting ATPase in sertolian EVs. Testosterone stimulation enhanced the abundance of inhibin-alpha, inhibin-beta, tissue-type plasminogen activator, epidermal growth factor-like protein 8, elongating factor 1-gamma and D-3-phosphoglycerate dehydrogenase. These results are likely to help determine the unknown molecular secretion of Sertoli cells., (Copyright © 2018. Published by Elsevier B.V.)
- Published
- 2018
- Full Text
- View/download PDF
8. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db/db mice with spontaneous diabetes mellitus.
- Author
-
Luca G, Arato I, Mancuso F, Calvitti M, Falabella G, Murdolo G, Basta G, Cameron DF, Hansen BC, Fallarino F, Baroni T, Aglietti MC, Tortoioli C, Bodo M, and Calafiore R
- Subjects
- Adipose Tissue cytology, Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2 therapy, Drug Compounding, Glucose Tolerance Test methods, Heterografts immunology, Insulin Resistance physiology, Male, Mice, Transgenic, Swine, Blood Glucose metabolism, Diabetes Mellitus, Type 2 immunology, Heterografts cytology, Homeostasis immunology, Sertoli Cells transplantation, Transplantation, Heterologous methods
- Abstract
Background: Increased abdominal fat and chronic inflammation in the expanded adipose tissue of obesity contribute to the development of insulin resistance and type 2 diabetes mellitus (T2D). The emerging immunoregulatory and anti-inflammatory properties of Sertoli cells have prompted their application to experimental models of autoimmune/inflammatory disorders, including diabetes. The main goal of this work was to verify whether transplantation of microencapsulated prepubertal porcine Sertoli cells (MC-SC) in the subcutaneous abdominal fat depot of spontaneously diabetic and obese db/db mice (homozygous for the diabetes spontaneous mutation [Lepr
db ]) would: (i) improve glucose homeostasis and (ii) modulate local and systemic immune response and adipokines profiles., Methods: Porcine prepubertal Sertoli cells were isolated, according to previously established methods and enveloped in Barium alginate microcapsules by a mono air-jet device. MC-SC were then injected in the subcutaneous abdominal fat depot of db/db mice., Results: We have preliminarily shown that graft of MC-SC restored glucose homeostasis, with normalization of glycated hemoglobin values with improvement of the intraperitoneal glucose tolerance test in 60% of the treated animals. These results were associated with consistent increase, in the adipose tissue, of uncoupling protein 1 expression, regulatory B cells, anti-inflammatory macrophages and a concomitant decrease of proinflammatory macrophages. Furthermore, the treated animals showed a reduction in inducible NOS and proinflammatory molecules and a significant increase in an anti-inflammatory cytokine such as IL-10 along with concomitant rise of circulating adiponectin levels. The anti-hyperglycemic graft effects also emerged from an increased expression of GLUT-4, in conjunction with downregulation of GLUT-2, in skeletal muscle and liver, respectively., Conclusions: Preliminarily, xenograft of MC-SC holds promises for an effective cell therapy approach for treatment of experimental T2D., (© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)- Published
- 2016
- Full Text
- View/download PDF
9. Terapeutic Potential of Microencapsulated Sertoli Cells in Huntington Disease.
- Author
-
Luca G, Bellezza I, Arato I, Di Pardo A, Mancuso F, Calvitti M, Falabella G, Bartoli S, Maglione V, Amico E, Favellato M, Basta G, Bodo M, Minelli A, Calafiore R, Frati L, and Squitieri F
- Subjects
- Animals, Animals, Newborn, Apoptosis genetics, Apoptosis physiology, Corpus Striatum cytology, Cyclooxygenase 2 metabolism, Cytokines genetics, Cytokines metabolism, Disease Models, Animal, Female, Gene Expression Regulation physiology, Humans, Huntingtin Protein genetics, Huntingtin Protein metabolism, Huntington Disease genetics, Huntington Disease mortality, Huntington Disease physiopathology, Male, Mice, Mice, Transgenic, Motor Activity physiology, Nitric Oxide Synthase Type II metabolism, Survival Analysis, Swine, Trinucleotide Repeats genetics, Drug Compounding methods, Huntington Disease surgery, Sertoli Cells physiology, Sertoli Cells transplantation
- Abstract
Introduction: Immune dysfunction, promoted by pro-inflammatory cytokines, plays a pivotal role in neurodegeneration associated with Huntington's disease., Aims: The aim of this study was to investigate the emerging immunoregulatory and antiinflammatory properties of Sertoli cells in Huntington's disease., Methods: The experimental R6/2 mouse model of Huntington's disease was treated by a single intraperitoneal injection of microencapsulated prepubertal porcine Sertoli cells and lifespan, motor performance and striatal inflammatory pattern have been evaluated., Results: The results of this study demonstrated that a single intraperitoneal injection of microencapsulated prepubertal porcine Sertoli cells uniquely improved performances and extended the life expectancy of R6/2 Huntington's disease mice, by immune dysfunction modulation in brain., Conclusions: This study highlights the immunomodulatory and trophic role of Sertoli cells that could be of help in the treatment of neurodegenerative disorders., (© 2016 John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
10. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice.
- Author
-
Chiappalupi S, Luca G, Mancuso F, Madaro L, Fallarino F, Nicoletti C, Calvitti M, Arato I, Falabella G, Salvadori L, Di Meo A, Bufalari A, Giovagnoli S, Calafiore R, Donato R, and Sorci G
- Subjects
- Animals, Anti-Inflammatory Agents metabolism, Cell Survival drug effects, Chronic Disease, Homeostasis drug effects, Injections, Intraperitoneal, Male, Mice, Inbred mdx, Muscles drug effects, Muscles physiopathology, Muscular Dystrophy, Animal physiopathology, Neuregulin-1 pharmacology, Recovery of Function drug effects, Sertoli Cells cytology, Sus scrofa, Up-Regulation drug effects, Utrophin metabolism, Drug Compounding, Muscles pathology, Muscular Dystrophy, Animal pathology, Sertoli Cells transplantation
- Abstract
Duchenne muscular dystrophy (DMD) is a genetic disease characterized by progressive muscle degeneration leading to impaired locomotion, respiratory failure and premature death. In DMD patients, inflammatory events secondary to dystrophin mutation play a major role in the progression of the pathology. Sertoli cells (SeC) have been largely used to protect xenogeneic engraftments or induce trophic effects thanks to their ability to secrete trophic, antiinflammatory, and immunomodulatory factors. Here we have purified SeC from specific pathogen-free (SPF)-certified neonatal pigs, and embedded them into clinical grade alginate microcapsules. We show that a single intraperitoneal injection of microencapsulated SPF SeC (SeC-MC) in an experimental model of DMD can rescue muscle morphology and performance in the absence of pharmacologic immunosuppressive treatments. Once i.p. injected, SeC-MC act as a drug delivery system that modulates the inflammatory response in muscle tissue, and upregulates the expression of the dystrophin paralogue, utrophin in muscles through systemic release of heregulin-β1, thus promoting sarcolemma stability. Analyses performed five months after single injection show high biocompatibility and long-term efficacy of SeC-MC. Our results might open new avenues for the treatment of patients with DMD and related diseases., (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
11. Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice.
- Author
-
Chiappalupi S, Luca G, Mancuso F, Madaro L, Fallarino F, Nicoletti C, Calvitti M, Arato I, Falabella G, Salvadori L, Di Meo A, Bufalari A, Giovagnoli S, Calafiore R, Donato R, and Sorci G
- Abstract
We report data about the effects of intraperitoneal (i.p.) injection of specific pathogen-free (SPF) porcine Sertoli cells (SeC) encapsulated into clinical grade alginate-based microcapsules (SeC-MC) on muscles of chronic and presymptomatic dystrophic, mdx mice. Mdx mouse is the best characterized animal model of Duchenne muscular dystrophy (DMD), an X-linked lethal myopathy due to mutation in the gene of dystrophin, which is crucial for myofiber integrity during muscle contraction. Our data show that three weeks after i.p. injection of SeC-MC significantly reduced adipose and fibrous tissue deposition, reduced macrophage infiltrate, and reduced numbers of damaged myofibers are found in muscles of 12-month-old mdx mice, which reproduce chronic DMD conditions. Compared with muscles of mock-treated mdx mice muscles of SeC-MC-treated mice show upregulation of the dystrophin paralogue, utrophin which is localized to the periphery of myofibers. Moreover, our data show that i.p. injection of SeC-MC into presymptomatic, 2-week-old mdx mice, although not fully preventing myofiber degeneration, results in protection against myofiber necrosis and muscle inflammation. Extensive discussion of these data can be found in Ref. [1].
- Published
- 2015
- Full Text
- View/download PDF
12. Long-term stability, functional competence, and safety of microencapsulated specific pathogen-free neonatal porcine Sertoli cells: a potential product for cell transplant therapy.
- Author
-
Luca G, Mancuso F, Calvitti M, Arato I, Falabella G, Bufalari A, De Monte V, Tresoldi E, Nastruzzi C, Basta G, Fallarino F, Lilli C, Bellucci C, Baroni T, Aglietti MC, Giovagnoli S, Cameron DF, Bodo M, and Calafiore R
- Subjects
- Alginates, Animals, Animals, Newborn, Cell Separation, Cell Transplantation methods, Cells, Cultured, Glucuronic Acid, Hexuronic Acids, Humans, Male, Mice, Sertoli Cells cytology, Sertoli Cells physiology, Specific Pathogen-Free Organisms, Swine, Sertoli Cells transplantation, Transplantation, Heterologous methods
- Abstract
Background: Porcine Sertoli cells (pSCs) have been employed for cell therapy in pre-clinical studies for several chronic/immune diseases as they deliver molecules associated with trophic and anti-inflammatory effects. To be employed for human xenografts, pSCs products need to comply with safety and stability. To fulfill such requirements, we employed a microencapsulation technology to increase pre-transplant storage stability of specific pathogen-free pSCs (SPF-pSCs) and evaluated the in vivo long-term viability and safety of grafts., Methods: Specific pathogen free neonatal pigs underwent testis excision under sterility. pSCs were isolated, characterized by immunofluorescence (IF) and cytofluorimetric analysis (CA) and examined in terms of viability and function [namely, production of anti-müllerian hormone (AMH), inhibin B, and transforming growth factor beta-1 (TFGβ-1)]. After microencapsulation in barium alginate microcapsules (Ba-MC), long-term SPF-pSCs (Ba-MCpSCs) viability and barium concentrations were evaluated at 1, 24 throughout 40 h to establish pre-transplant storage conditions., Results: The purity of isolated pSCs was about 95% with negligible contaminating cells. Cultured pSCs monolayers, both prior to and after microencapsulation, maintained high function and full viability up to 24 h of storage. At 40 h post-encapsulation, pSCs viability decreased to 80%. Barium concentration in Ba-MCpSCs lagged below the normal maximum daily allowance and was stable for 4 months in mice with no evident side effects., Conclusions: Such results suggest that this protocol for the isolation and microencapsulation of pSCs is compatible with long-haul transportation and that Ba-MCpSCs could be potentially employable for xenotransplantation., (© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
13. In vitro cadmium effects on ECM gene expression in human bronchial epithelial cells.
- Author
-
Baroni T, Lilli C, Bellucci C, Luca G, Mancuso F, Fallarino F, Falabella G, Arato I, Calvitti M, Marinucci L, Muzi G, Dell'Omo M, Gambelunghe A, and Bodo M
- Subjects
- Apoptosis drug effects, Cell Line, Collagen genetics, Down-Regulation, Gene Expression, Humans, Integrins genetics, Metalloproteases genetics, Real-Time Polymerase Chain Reaction, Signal Transduction, Tenascin genetics, Transforming Growth Factor beta metabolism, Up-Regulation, Vitronectin genetics, Bronchi cytology, Cadmium toxicity, Epithelial Cells drug effects, Extracellular Matrix metabolism, Extracellular Matrix Proteins genetics
- Abstract
Occupational and environmental exposure to the heavy metal cadmium (Cd) and its inhalation from cigarette smoke are associated with emphysema. Many growth factors and extracellular matrix (ECM) cell signaling molecules are directly involved in the epithelial bronchial cell pathway. This study investigated the direct effects of Cd on the production of several ECM components in human bronchial epithelial cells (BEAS-2B) that were exposed in vitro for 48 h to sub-toxic and toxic concentrations of Cd. Gene expression of collagens, metalloproteases (MMPs), integrins, tenascin and vitronectin were quantified by RT-PCR. To study apoptosis cascade, annexin assay and cellular cytotoxicity by MTT assay were performed. We also investigated whether an imbalance in the TGFβ/TGFβ receptor (TGFβR) expression mediated Cd effects. The results showed the sub-toxic Cd dose significantly increased tenascin, vitronectin, β1 and β5 integrin gene expression. The toxic Cd dose decreased type IV and V collagen, α1, α2 and β3 integrins. Both Cd doses down-regulated type I collagen and up-regulated metalloproteases. Each Cd dose caused a different imbalance in the complex pattern of TGFβ and its receptors. No alteration in classic apoptotic marker protein expression was observed in presence of the sub-toxic dose of Cd, suggesting this metal alters ECM production without apoptotic activation. In conclusion, all these data show even sub-toxic Cd dose exposure alters the specific gene expression of several ECM components that are crucially implicated in the mechanical properties of lung parenchyma supporting the hypothesis that the mechanism underlying Cd-induced lung disease may involve downstream changes in TGFβ/TGFβR signaling., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.